Tymlos Injection, Solution
Product Images NDC 70539-001

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Tymlos (NDC 70539-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Radius Health, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tym00 0000 01

FDA Label Image

Tym00 0000 02

This is a description of a study on patient nonvertebral fracture incidence for alendronate monotherapy. The graph shows the incidence of fractures over a period of 25 months, with alendronate treatment starting at 19 months. The study compared the efficacy of alendronate to placebo and TYMLOS over a period of 25 months.*

FDA Label Image

Tym00 0000 03

This is a description of the TYMLOS pen, including the cartridge, cartridge holder, pen cap, injection button, dose knob, dose display window, and lot/exp information. There are two views of the pen provided: a front view and a rear view.*

FDA Label Image

Tym00 0000 04

This text is a list of items that are not included with the TYMLOS pen but are necessary parts of the pen needle, including the inner and outer pen needle caps, and the protective paper for the pen needle. The figure C likely refers to an accompanying diagram or illustration.*

FDA Label Image

Tym00 0000 05

FDA Label Image

Tym00 0000 06

FDA Label Image

Tym00 0000 07

FDA Label Image

Tym00 0000 08

FDA Label Image

Tym00 0000 09

FDA Label Image

Tym00 0000 10

FDA Label Image

Tym00 0000 11

FDA Label Image

Tym00 0000 12

FDA Label Image

Tym00 0000 13

FDA Label Image

Tym00 0000 14

FDA Label Image

Tym00 0000 15

FDA Label Image

Tym00 0000 16

FDA Label Image

Tym00 0000 17

FDA Label Image

Tym00 0000 18

FDA Label Image

Tym00 0000 19

FDA Label Image

Tym00 0000 20

FDA Label Image

Tym00 0000 21

FDA Label Image

Tym00 0000 22

TYMLOS' is a medication that is given through subcutaneous injection using a pre-filled pen. It contains 3120 mcg/1.56 mL (2000 mg/m) of ahaloparatide. The medication should be kept refrigerated until the first use, after which it can be stored at room temperature for up to 30 days. Unused portions should be discarded after 30 days. Before injecting, read the instructions for use carefully.*

FDA Label Image

Tym00 0000 23

FDA Label Image

Tym00 0000 24

TYMLOS' (abaloparatide) injection is a prescription drug for subcutaneous use and is meant for single patient use only. Each pre-filled pen contains enough doses for 30 injections. The medication needs to be kept refrigerated at 2°C - 8°C (36°F - 46°F) before the first use and after that, it can be stored for up to 30 days at a temperature range of 20°C - 25°C (68°F - 77°F). Unused portions should be discarded 30 days after opening. Before injecting, it is important to read the instructions for use. The drug is manufactured by Radius Health, Inc. in Boston, MA.*

FDA Label Image

Tym00 0000 25

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.